当前位置: X-MOL 学术Bioorg. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold
Bioorganic & Medicinal Chemistry ( IF 3.5 ) Pub Date : 2017-10-25 , DOI: 10.1016/j.bmc.2017.10.012
Srinivasulu Cherukupalli , Girish A. Hampannavar , Sampath Chinnam , Balakumar Chandrasekaran , Nisar Sayyad , Francis Kayamba , Rajeshwar Reddy Aleti , Rajshekhar Karpoormath

Pyrazolo[4,3-d]pyrimidine, a fused heterocycle bearing pyrazole and pyrimidine portions has gained a significant attention in the field of bioorganic and medicinal chemistry. Pyrazolo[4,3-d]pyrimidine derivatives have demonstrated numerous pharmacological activities particularly, anti-cancer, anti-infectious, phosphodiesterase inhibitors, adenosine antagonists and cytokinin antagonists etc. This review extensively unveils the synthetic and pharmacological diversity with special emphasis on structural variations around pyrazolo[4,3-d]pyrimidine scaffold. This endeavour has thus uncovered the medicinal worthiness of pyrazolo[4,3-d]pyrimidine framework. To the best of our knowledge this review is the first compilation on synthetic, medicinal and structure activity relationship (SAR) aspects of pyrazolo[4,3-d]pyrimidines since 1956.



中文翻译:

吡唑并[4,3- d ]嘧啶支架的合成和药物学前景评价

吡唑并[4,3- d ]嘧啶是带有吡唑和嘧啶部分的稠合杂环,在生物有机和药物化学领域引起了广泛关注。吡唑并[4,3- d ]嘧啶衍生物已显示出许多药理活性,特别是抗癌,抗感染,磷酸二酯酶抑制剂,腺苷拮抗剂和细胞分裂素拮抗剂等。该综述广泛揭示了合成和药理学多样性,特别着重于结构变异围绕吡唑并[4,3- d ]嘧啶骨架。因此,这项努力发现了吡唑并[4,3- d]嘧啶骨架。据我们所知,本综述是自1956年以来关于吡唑并[4,3- d ]嘧啶的合成,药物和结构活性关系(SAR)方面的第一本汇编。

更新日期:2017-10-25
down
wechat
bug